ValiRx PLC
08 May 2008
ValiRx plc
(the 'Company')
Issue of Equity
Further to the announcements on 7 April 2008 and 2 May 2008, the Company
announces that due to additional interest it has raised a further amount of up
to £300,000 via a placing of new ordinary shares of 6p each in the Company
('Ordinary Shares') at 6p per share ('Placing Shares') with a warrant attached.
Application will be made for the Placing Shares to be admitted to trading on AIM
and dealings are expected to commence on 13 May 2008 ('Admission').
A further announcment will be made before Admission confirming the final number
of Placing Shares.
Attached to each Placing Share will be a warrant to subscribe for one new
Ordinary Share at 10p per share for a period of three years from Admission.
Contact Details:
ValiRx Plc WH Ireland Limited GTH Communications
Dr Satu Vainikka David Youngman Toby Hall / Brooke Paul
+44 (0) 203 008 4416 +44 (0) 161 832 2174 +44 (0) 20 7153 8035
This information is provided by RNS
The company news service from the London Stock Exchange
IOEVVLBBVEBBBBB
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.